myTomorrows Competitors and Similar CompaniesClear all
myTomorrows's competitors and similar companies include Quark Pharmaceuticals, mClinica, ImmuPharma and Cambridge Epigenetix.
 myTomorrows myTomorrows is the online platform providing early access to the latest drug innovations. |  Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  mClinica mClinica provides data, analytics, and patient engagement tools for healthcare organizations in Asia's emerging markets. |  ImmuPharma ImmuPharma is a pharmaceutical company focused on developing innovative drugs to treat serious medical conditions in specialist therapeutic areas. |  Cambridge Epigenetix Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. | |
Founding Date | Founding Date 2013 | Founding Date 1994 | Founding Date 2012 | Founding Date 1999 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Amsterdam, NL HQ New York, US | Locations Newark, US HQ | Locations SG HQ Petaling Jaya, MY Taguig, PH | Locations London, GB HQ Mulhouse, FR Sarnen, CH London, GB | Locations Little Chesterford, GB HQ Wilmslow, GB |
Employees | Employees 1222% decrease | Employees 781% decrease | Employees 2922% increase | Employees 5 | Employees 1121% decrease |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income (£2.5m) (FY, 2024) | Net income (£86.2k) (FY, 2012) |
Funding | |||||
Latest funding round | Latest funding round $ 10.5m (over 9 years ago) | Latest funding round $ 10m (almost 16 years ago) | Latest funding round $ 6.3m (over 9 years ago) | Latest funding round N/A | Latest funding round $ 30m (about 8 years ago) |
Total funding raised | Total funding raised $ 22.1m | Total funding raised $ 37m | Total funding raised $ 6.3m | Total funding raised N/A | Total funding raised $ 56.5m |
For sources of this data, please see the company profile
View Company Profiles
Quark Pharmaceuticals
HQ
Newark, US
Employees
78↓ 1% decrease
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View companymClinica
HQ
SG
Employees
292↑ 2% increase
mClinica provides data, analytics, and patient engagement tools for healthcare organizations in Asia's emerging markets.
View companyImmuPharma
HQ
London, GB
Employees
5
ImmuPharma is a pharmaceutical company focused on developing innovative drugs to treat serious medical conditions in specialist therapeutic areas.
View companyCambridge Epigenetix
HQ
Little Chesterford, GB
Employees
112↓ 1% decrease
Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
View company